HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

DRIO

DarioHealth Corp. (NASDAQ)

Healthcare — Health Information Services

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

None 4 analysts
$6.75
+$0.15 (+2.27%)
Target: $18.50 (174.1%)
Sign in to add DRIO to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$49.36M
P/E Ratio (TTM)-
Forward P/E-9.93
EPS (TTM)$-8.50
Dividend Yield-
Profit Margin-192.23%
Revenue Growth-17.30%
ROE-59.87%
Debt/Equity51.00
Recommendation None
Analyst Target$18.50
Analysts4
Indexes NASDAQ

Technical Indicators

RSI (14)42.4
Beta1.08
SMA 20-
SMA 40-
52-Week High$17.74
52-Week Low$5.85
50-Day Avg$7.44
200-Day Avg$10.34
Avg Volume11.8K
Volume10.3K

Performance Analysis

NEUTRAL

DRIO presents a mixed picture with both positive and negative indicators.

+ Trading near its 52-week low ($5.84), which could present a value opportunity.
~ RSI at 42.4 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- Revenue declined 17.3% year-over-year.
- Operating at a loss with -192.2% margin.
~ Wall Street consensus is "none" from 4 analysts.
+ Average analyst target of $18.50 implies 174.1% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:06 UTC

Back to Screener Export Report